George W L, Lewis R P, Meyer R D
Antimicrob Agents Chemother. 1978 Mar;13(3):484-9. doi: 10.1128/AAC.13.3.484.
The in vitro antibacterial activity of piperacillin and cefuroxime against 180 isolates of cephalothin-resistant Enterobacteriaceae and of piperacillin against 46 isolates of Pseudomonas aeruginosa was determined. Amikacin, gentamicin, carbenicillin, cefoxitin, and cefamandole were included for comparison. The activities of piperacillin and carbenicillin against Enterobacteriaceae were comparable. Piperacillin was appreciably more active against Pseudomonas than carbenicillin and was equivalent in activity to amikacin on a weight basis. The following beta-lactam agents were the most active against the indicated organisms (in parentheses): cefoxitin (indole-positive Proteus spp.), cefuroxime and cefoxitin, (Klebsiella spp.), piperacillin (Enterobacter spp.), cefuroxime and cefoxitin (E. coli), piperacillin and cefoxitin (Serratia spp.), and cefoxitin (Providencia spp.). Amikacin inhibited 98% of Enterobacteriaceae at clinically achievable serum levels.
测定了哌拉西林和头孢呋辛对180株耐头孢噻吩肠杆菌科细菌的体外抗菌活性,以及哌拉西林对46株铜绿假单胞菌的体外抗菌活性。同时纳入阿米卡星、庆大霉素、羧苄西林、头孢西丁和头孢孟多作为对照。哌拉西林和羧苄西林对肠杆菌科细菌的活性相当。哌拉西林对铜绿假单胞菌的活性明显高于羧苄西林,按重量计算其活性与阿米卡星相当。以下β-内酰胺类药物对指定菌属活性最强(括号内为菌属):头孢西丁(吲哚阳性变形杆菌属)、头孢呋辛和头孢西丁(克雷伯菌属)、哌拉西林(肠杆菌属)、头孢呋辛和头孢西丁(大肠埃希菌)、哌拉西林和头孢西丁(沙雷菌属)以及头孢西丁(普罗威登斯菌属)。在临床可达到的血清浓度下,阿米卡星可抑制98%的肠杆菌科细菌。